Web Analytics

3 Latest Announced Rounds

  • $75,000,000
    Series D

    4 Investors

    Software Development
    Feb 23rd, 2024
  • $150,000,000
    Series B
    Industrial Machinery Manufacturing
    Feb 23rd, 2024
  • Undisclosed Amount
    Seed

    3 Investors

    Technology, Information and Internet
    Feb 23rd, 2024
$1,220.18M Raised in 78 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Sable Bio

start up
United Kingdom - London
  • 06/02/2024
  • Pre-Seed
  • $1,883,707

Prevent target safety failures with unique data insights and cutting-edge approaches.

Better prediction of drug safety could help patients and prevent hugely costly trial failures. Our advanced workflows assess clinical side effects and predict potential risks for drugs in development using a suite of data modalities.

Empower your drug development process with our state-of-the-art solutions. Build trust with industry-leading validation across several proof points. Gain deeper insights into target safety, minimize risks, and optimize assay validation strategies.


Related People

Josh Almond-ThynneCo Founder

Josh Almond-Thynne United Kingdom - London, England

N/A